Predictive biomarkers of response to immune checkpoint inhibitors in mismatch repair-deficient endometrial cancer
The introduction of immune checkpoint inhibitors (ICIs) has represented a major therapeutic breakthrough for patients with mismatch repair-deficient (MMRd) endometrial cancer (EC). However, despite initial clinical success, a considerable subset of patients does not experience meaningful clinical be...
Na minha lista:
| Principais autores: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publishing
2026-03-01
|
| coleção: | Therapeutic Advances in Medical Oncology |
| Acesso em linha: | https://doi.org/10.1177/17588359261423888 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|